Consolidated Statement Of Income

Kubota Pharmaceutical Holdings Co., Ltd. - Filing #7271008

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of income
Statement of income
Operating revenue
258,503,000 JPY
214,111,000 JPY
Cost of sales
2,239,000 JPY
JPY
Operating expenses
Selling, general and administrative expenses
Depreciation
128,000 JPY
4,350,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
66,839,000 JPY
65,922,000 JPY
Operating expenses
Operating expenses
640,436,000 JPY
360,000,000 JPY
Ordinary profit (loss)
-1,295,091,000 JPY
-732,613,000 JPY
Operating profit (loss)
-381,933,000 JPY
-145,889,000 JPY
Operating expenses
Research and development expenses
195,522,000 JPY
JPY
General and administrative expenses
Salaries
Non-operating income
Interest income
8,116,000 JPY
6,187,000 JPY
Non-operating income
9,007,000 JPY
17,265,000 JPY
Miscellaneous income
JPY
257,000 JPY
Cost of sales
Selling, general and administrative expenses
Extraordinary income
48,089,000 JPY
7,941,000 JPY
Non-operating expenses
Non-operating expenses
922,165,000 JPY
603,988,000 JPY
Share issuance costs
8,443,000 JPY
4,166,000 JPY
Extraordinary losses
54,628,000 JPY
JPY
Impairment losses
54,628,000 JPY
JPY
Profit (loss) before income taxes
-1,301,630,000 JPY
-724,671,000 JPY
Extraordinary income
Income taxes - current
1,360,000 JPY
1,360,000 JPY
Extraordinary losses
Profit (loss)
-1,302,990,000 JPY
-1,302,990,000 JPY
-1,302,990,000 JPY
-726,031,000 JPY
-726,031,000 JPY
-726,031,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.